Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Open Prairie Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Open Prairie Ventures

Open Prairie Ventures

Operating

Open Prairie Ventures: A private equity fund manager investing in startups and early-stage ventures across diverse sectors.

Location
Jefferson, IL, US
Founded
1997
Firm
Compare
Portfolio
Employees
Website

Investments

Vytelle
Vytelle

Total Raised

$33.2M

Rounds

3

Series B$20MApril 2023
Series A$13.2MSeptember 2021
LandscapeHub
LandscapeHub

Total Raised

$19.6M

Rounds

5

Series A$9MFebruary 2022
HerdDogg
HerdDogg

Total Raised

$13.5M

Rounds

8

Series A$4MJanuary 2021
FreshFry
FreshFry

Total Raised

$8.2M

Rounds

9

Series Unknown$3.3MJuly 2020
Farmer Focus
Farmer Focus

Total Raised

$27.8M

Rounds

4

Series Unknown$15MDecember 2019
Nutriati
Nutriati
Acquired

Total Raised

$26.4M

Rounds

5

Series C$12.7MDecember 2019
Agrivida
Agrivida
Series A

Total Raised

$72.8M

Rounds

17

Series A$8MJuly 2019
Vestaron
Vestaron

Total Raised

$264.9M

Rounds

15

Series B$40MJune 2019
Series D$18MAugust 2016
Series C$4MOctober 2014
Series C$10MAugust 2014
Series B$10.2MMay 2012
Green Dot Bioplastics
Green Dot Bioplastics

Total Raised

$7.9M

Rounds

3

Series A$6.5MFebruary 2019
MyAgData
MyAgData

Total Raised

$5.5M

Rounds

5

Debt Financing$2MAugust 2018
Tillerman
Tillerman

Total Raised

$5.2M

Rounds

1

Debt Financing$5.2MAugust 2018
NewLeaf Symbiotics
NewLeaf Symbiotics

Total Raised

$134.6M

Rounds

7

Series C$30MJuly 2017
Series B$17MSeptember 2014
Series A$7MJanuary 2013
Innara Health
Innara Health

Total Raised

$14.9M

Rounds

6

Series B$3.7MApril 2015
Series A$3MDecember 2010
Compact Particle Acceleration
Compact Particle Acceleration

Total Raised

$6.5M

Rounds

1

Series Unknown$6.5MApril 2012
Novita Therapeutics
Novita Therapeutics

Total Raised

$7.7M

Rounds

6

Series A$3MMay 2011
Cernium
Cernium

Total Raised

$20.3M

Rounds

3

Series Unknown$2.8MJuly 2003